Effects of ertugliflozin on uric acid and gout-related outcomes: post hoc analyses from VERTIS CV

被引：0
|
作者：
Sridhar, V. S. [1 ,2 ]
Cosentino, F. [3 ,4 ]
Dagogo-Jack, S. [5 ]
Pratley, R. [6 ]
Frederich, R. [7 ]
Essex, M. Noyes [8 ]
Maldonado, M. [9 ]
Liu, C. -C. [10 ]
Mancuso, J. P. [11 ]
Cherney, D. Z. I. [1 ,2 ]
机构：
[1] Univ Hlth Network, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Karolinska Inst, Unit Cardiol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[6] AdventHlth Translat Res Inst, Orlando, FL USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, New York, NY USA
[9] MSD Ltd, London, England
[10] Merck & Co Inc, Kenilworth, NJ USA
[11] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
621
引用
收藏
页码：S318 / S319
页数：2
相关论文
共 50 条
  • [1] Effects of Ertugliflozin on Uric Acid and Gout-Related Outcomes: Post Hoc Analyses from VERTIS CV
    Sridhar, Vikas S.
    Cosentino, Francesco
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Frederich, Robert
    Essex, Margaret N.
    Maldonado, Mario
    Liu, Chih-Chin
    Mancuso, James P.
    Cherney, David
    [J]. DIABETES, 2022, 71
  • [2] Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV
    Sridhar, Vikas S.
    Cosentino, Francesco
    Dagogo-Jack, Samuel
    Mcguire, Darren K.
    Pratley, Richard E.
    Cater, Nilo B.
    Noyes Essex, Margaret
    Mancuso, James P.
    Zhao, Yujie
    Cherney, David Z. I.
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [3] Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
    Cosentino, Francesco
    Cannon, Christopher P.
    Frederich, Robert
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Mancuso, James P.
    Maldonado, Mario
    Cater, Nilo B.
    Wang, Shuai
    McGuire, Darren K.
    [J]. CIRCULATION, 2022, 146 (08) : 652 - 654
  • [4] Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial
    Cosentino, F.
    Cannon, C. P.
    Cherney, D. Z. I.
    Dagogo-Jack, S.
    Pratley, R. E.
    Charbonnel, B.
    Shih, W. J.
    Mancuso, J. P.
    Maldonado, M.
    Frederich, R.
    Cater, N. B.
    Wang, S.
    McGuire, D. K.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2650 - 2650
  • [5] The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV
    Cherney, David Z., I
    Cosentino, Francesco
    Pratley, Richard E.
    Dagogo-Jack, Samuel
    Frederich, Robert
    Maldonado, Mario
    Liu, Jie
    Pong, Annpey
    Liu, Chih-Chin
    Cannon, Christopher P.
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1114 - 1122
  • [6] Cardiorenal outcomes with ertugliflozin by baseline cardiorenal medications: an analysis from VERTIS CV
    Cannon, C. P.
    Cosentino, F.
    McGuire, D. K.
    Charbonnel, B.
    Dagogo-Jack, S.
    Pratley, R. E.
    Shih, W. J.
    Maldonado, M.
    Pong, A.
    Gantz, I.
    Frederich, R.
    Mancuso, J. P.
    Masiukiewicz, U.
    Cherney, D. Z. I.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 29 - 30
  • [7] Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV
    Cherney, David
    Cosentino, Francesco
    Mcguire, Darren K.
    Charbonnel, Bernard
    Dagogo-Jack, Samuel
    Pratley, Richard E.
    Shih, Weichung J.
    Maldonado, Mario
    Pong, Annpey
    Gantz, Ira
    Frederich, Robert
    Mancuso, James P.
    Masiukiewicz, Urszula
    Cannon, Christopher P.
    [J]. DIABETES, 2021, 70
  • [8] Long-Term Ertugliflozin Treatment and Incidence of Hypoglycemia: Analyses from VERTIS CV
    Dagogo-Jack, Samuel
    Cannon, Christopher P.
    Cherney, David
    Cosentino, Francesco
    McGuire, Darren K.
    Liu, Jie
    Liu, Chih-Chin
    Frederich, Robert
    Mancuso, James P.
    Pratley, Richard E.
    [J]. DIABETES, 2022, 71
  • [9] Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial
    Cherney, David Z. I.
    Cosentino, Francesco
    Dagogo-Jack, Samuel
    McGuire, Darren K.
    Pratley, Richard
    Frederich, Robert
    Maldonado, Mario
    Liu, Chih-Chin
    Liu, Jie
    Pong, Annpey
    Cannon, Christopher P.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (09): : 1345 - 1354
  • [10] Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial
    Cherney, David Z. I.
    Dagogo-Jack, Samuel
    Cosentino, Francesco
    Pratley, Richard E.
    Frederich, Robert
    Maldonado, Mario
    Liu, Chih-Chin
    Cannon, Christopher P.
    VERTIS CV Investigators
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (08): : 1782 - 1792
12345